American Cancer Society (ACS) 2018, ‘Risk factors for acute myeloid leukaemia (AML)’, viewed 28 January 2020 https://www.cancer.org/cancer/acute-myeloid-leukemia/causes-risks-prevention/risk-factors.html.

Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. 2016, ‘The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia’, Blood, vol. 127, no. 20, pp. 2391–2405.

Australian Adult Cancer Pain Management Guideline Working Party 2019, Australian adult cancer pain management guideline: ‘Cancer pain management in adults’, Cancer Council Australia, Sydney, viewed 6 June 2019, https://wiki.cancer.org.au/australiawiki/index.php?oldid=191646.

Australian Cancer Survivorship Centre 2016, ‘Survivorship care planning’, viewed 2 October 2020, https://www.petermac.org/sites/default/files/page/downloads/Survivorship_Care_Planning.pdf.

Australian Cancer Survivorship Centre 2019, Community support organisations’ cancer survivorship care consensus statement, viewed 10 February 2020, https://www.petermac.org/sites/default/files/media-uploads/NGO_ConsensusStatement.pdf.

Australian Clinical Trials 2015, ‘Potential benefits and risks’, National Health and Medical Research Council, Department of Industry, Innovation and Science, Australian Government, Canberra, viewed 24 July 2019, https://www.australianclinicaltrials.gov.au/why-be-part-clinical-trial/potential-benefits-and-potential-risks.

Australian Commission on Safety and Quality in Health Care (ACSQHC) 2014, Health literacy: taking action to improve safety and quality, ACSQHC, Sydney, viewed 18 February 2020, https://www.safetyandquality.gov.au/sites/default/files/migrated/Health-Literacy-Taking-action-to-improve-safety-and-quality.pdf.

Australian Commission for Safety and Quality in Health Care (ACSQHC) 2015, Credentialing health practitioners and defining their scope of clinical practice: a guide for managers and practitioners, ACSQHC, Sydney, viewed 18 February 2020, https://www.safetyandquality.gov.au/publications-and-resources/resource-library/credentialing-health-practitioners-and-defining-their-scope-clinical-practice-guide-managers-and-practitioners.

Australian Commission on Safety and Quality in Health Care (ACSQHC) 2017, National Safety and Quality Health Service Standards guide for hospitals, ACSQHC, Sydney, viewed 18 February 2020, https://www.safetyandquality.gov.au/wp-content/uploads/2017/12/National-Safety-and-Quality-Health-Service-Standards-Guide-for-Hospitals.pdf.

Australian Commission on Safety and Quality in Health Care (ACSQHC) 2019a, Person-centred care, ACSQHC, Sydney, viewed 15 May 2020, https://www.safetyandquality.gov.au/our-work/partnering-consumers/person-centred-care.

Australian Commission on Safety and Quality in Health Care (ACSQHC) 2019b, Australian Hospital Patient Experience Question Set, ACSQHC, Sydney, viewed 25 March 2020, https://www.safetyandquality.gov.au/our-work/indicators-measurement-and-reporting/australian-hospital-patient-experience-question-set.

Australian Commission for Safety and Quality in Health Care (ACSQHC) 2020, ‘NSQHS Standards user guide for medication management in cancer care’, ACSQHC, Sydney, viewed 16 April 2020, https://www.safetyandquality.gov.au/publications-and-resources/resource-library/nsqhs-standards-user-guide-medication-management-cancer-care.

Australian Health Ministers’ Advisory Council (AHMAC) 2011, A national framework for advance care directives, Council of Australian Governments Health Council, Adelaide, viewed 22 July 2019, http://www.coaghealthcouncil.gov.au/Portals/0/A%20National%20Framework%20for%20Advance%20Care%20Directives_September%202011.pdf.

Australian Institute of Health and Welfare (AIHW) 2016, Australia’s health 2016, Australia’s health series no. 15. Cat. no. AUS 199, AIHW, Canberra.

Australian Institute of Health and Welfare (AIHW) 2017, Access to health services by Australians with disability, viewed 20 February 2020, https://www.aihw.gov.au/reports/disability/access-health-services-disability/contents/content.

Australian Institute of Health and Welfare (AIHW) 2018, Australia’s health 2018, Australia’s health series no. 16. Cat. no. AUS 221, AIHW, Canberra.

Australian Institute of Health and Welfare (AIHW) 2019, Cancer in Australia 2019, Cancer series no. 119. Cat. No. CAN 123, AIHW, Canberra.

AYA Cancer Fertility Preservation Guidance Working Group 2014, Fertility preservation for AYAs diagnosed with cancer: guidance for health professionals, Cancer Council Australia, Sydney, viewed 20 July 2020, https://wiki.cancer.org.au/australia/COSA:AYA_cancer_fertility_preservation/Introduction.

Breems DA, Van Putten WL, Huijgens PC, Ossenkoppele GJ, Verhoef GE, Verdonck LF, et al. 2005, ‘Prognostic index for adult patients with acute myeloid leukemia in first relapse’, Journal of Clinical Oncology, vol. 23, no. 9, pp. 1967–1978.

Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, et al. 2018, ‘Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT’, Bone Marrow Transplant, vol. 53, no. 5, pp. 535–555.

Cancer Australia 2015, National Aboriginal and Torres Strait Islander cancer framework, Cancer Australia, Surry Hills, viewed 24 August 2017, https://www.canceraustralia.gov.au/publications-and-resources/cancer-australia-publications/national-aboriginal-and-torres-strait-islander-cancer-framework.

Cancer Australia 2017, Principles of cancer survivorship, Australian Government, Sydney, viewed 18 February 2020, https://canceraustralia.gov.au/sites/default/files/publications/principles-cancer-survivorship/pdf/pocs_-_principles_of_cancer_survivorship.pdf.

Cancer Australia 2019a, Principles of multidisciplinary care, Australian Government, Sydney, viewed 18 July 2019, https://canceraustralia.gov.au/system/tdf/guidelines/all_about_multidisciplinary_care.pdf?file=1&type=node&id=3551.

Cancer Australia 2019b, ‘Cancer incidence’, viewed 18 February 2020, https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence.

Cancer Australia 2020, Cancer care in the time of COVID-19: a conceptual framework for the management of cancer during a pandemic, Australian Government, Sydney, viewed 3 September 2020, https://www.canceraustralia.gov.au/publications-and-resources/cancer-australia-publications/cancer-care-time-covid-19-conceptual-framework-management-cancer-during-pandemic.

Cancer Council Australia 2018, ‘Prevention’, Cancer Council Australia, Sydney, viewed 18 July 2019, https://www.cancer.org.au/preventing-cancer/.

Cancer Council Australia 2019, ‘Complementary and alternative therapies’, Cancer Council Australia, Sydney, viewed 22 July 2019, https://www.cancer.org.au/about-cancer/treatment/complementary-therapies-and-cancer.html.

Cancer Council Victoria 2019, ‘Palliative care’, Cancer Council Victoria, viewed 7 October 2019, https://www.cancervic.org.au/cancer-information/treatments/treatments-types/palliative_care/palliative-care-treatment.html.

Cancer Research in Primary Care 2016, Principles statement: Shared care, PC4 Shared Care Working Group, Melbourne, viewed 4 October 2019, http://pc4tg.com.au/wp-content/uploads/2016/07/PC4-Principles-Statement-shared-care-2016-1.pdf.

Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, et al. 1998, ‘Chemotherapy compared with autologous or allogeneic transplantation in the management of acute myeloid leukaemia in first remission’, New England Journal of Medicine, no. 339, pp. 1649–1656.

Clinical Oncology Society of Australia (COSA) 2013, Special Issue: COSA’s 40th Annual Scientific Meeting, Cancer Care Coming of Age, 12–14 November 2013, Adelaide Convention Centre, Asia-Pacific Journal of Clinical Oncology, vol. 9, no. 3, pp. 61–98.

Clinical Oncology Society of Australia (COSA) 2014, Psychosocial management of AYAs diagnosed with cancer: guidance for health professionals, COSA, Sydney, viewed 7 October 2019, http://wiki.cancer.org.au/australia/COSA:Psychosocial_management_of_AYA_cancer_patients.

Clinical Oncology Society of Australia (COSA) 2015, Cancer care coordinator: position statement, COSA, Sydney, viewed 22 July 2019, https://www.cosa.org.au/media/332296/cancer-care-coordinator-position-statement_final-endorsed-by-council_161115_cnsa-logo.pdf.

Clinical Oncology Society of Australia (COSA) 2016, Australasian tele-trial model: access to clinical trials closer to home using tele-health a national guide for implementation, v1.7, COSA, Sydney, viewed 18 July 2019, https://www.cosa.org.au/media/332325/cosa-teletrial-model-final-19sep16.pdf.

Clinical Oncology Society of Australia (COSA) 2018, COSA position statement on exercise in cancer care, COSA, Sydney, viewed 22 July 2019, https://www.cosa.org.au/media/332488/cosa-position-statement-v4-web-final.pdf.

Commonwealth Department of Health 2017, Out-of-pocket expenses for private medical treatment (informed financial consent), Commonwealth of Australia, Canberra.

Cormie P, Atkinson M, Bucci L, Cust A, Eakin E, Hayes S, et al. 2018, ‘Clinical Oncology Society of Australia position statement on exercise in cancer care’, Medical Journal of Australia, vol. 209, no. 4, pp. 184–187.

Cormie P, Zopf EM, Zhang X, Schmitz KH 2017, ‘The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects’, Epidemiologic Reviews, vol. 39, no. 1, pp. 71–92.

Davis JR, Benjamin DJ, Jonas BA 2018, ‘New and emerging therapies for acute myeloid leukaemia’, Journal of Investigative Medicine, vol. 66, pp. 1088–1095.

Decoster L, Van Puyvelde K, Mohile S, Wedding U, Basso U, Colloca G, et al. 2015, ‘Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations’, Annals of Oncology, vol. 26, no.1, pp. 288–300.

Department of Human Services (DHS) 2020, ‘Leukaemia – acute myeloid leukaemia’, viewed 29 January 2020, https://www.humanservices.gov.au/organisations/health-professionals/services/medicare/written-authority-required-drugs/drug-program-or-condition/leukaemia-acute-myeloid-leukaemia.

DiNardo CD, Wei AH 2020, ‘How I treat acute myeloid leukemia in the era of new drugs’, Ash Publications, vol. 135, no. 2, pp. 85–96.

Döhner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, Dombret H, et al. 2010, ‘Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet’, Blood, vol. 115, no. 3, pp. 453–474.

Döhner H, Estey E, Grimwalde D, Amadori S, Appelbaum FR, et al. 2017, ‘Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel’, Blood, vol. 129, no. 4, pp. 424–447.

Döhner H, Weisdorf DJ, Bloomfield CD 2015, ‘Acute myeloid leukemia’, The New England Journal of Medicine, vol. 373, no. 12, pp. 1136–1152.

eviQ 2019a, ‘Safe handling and waste management of hazardous drugs’, Cancer Institute NSW, Sydney, viewed 22 July 2019, https://www.eviq.org.au/clinical-resources/administration-of-antineoplastic-drugs/188-safe-handling-and-waste-management-of-hazardou.

eviQ 2019b, ‘Acute myeloid leukaemia induction/consolidation/maintenance with midostaurin treatment overview’, viewed 29 January 2020, https://www.eviq.org.au/haematology-and-bmt/leukaemias/acute-myeloid-leukaemia/3520-acute-myeloid-leukaemia-induction-consolidati.

Emery J 2014, ‘Cancer survivorship – the role of the GP’, Australian Family Physician, vol. 43, no. 8, pp. 521–525.

Ferrari A, Thomas D, Franklin A, Hayes-Lattin B, Mascarin M, van der Graaf W, et al. 2010, ‘Starting an adolescent and young adult program: some success stories and some obstacles to overcome’, Journal of Clinical Oncology, vol. 28, no. 32, pp. 4850–4857.

Fitch M 2000, ‘Supportive care for cancer patients’, Hospital Quarterly, vol. 3, no. 4, pp. 39–46.

Fitch MI 2008, ‘Supportive care framework’, Canadian Oncology Nursing Journal, vol. 18, no. 1, pp. 6–14.

Ganzel C, Mathews V, Alimoghaddam K, Ghavamzadeh A, Kuk D, Devlin S, et al. 2016, ‘Autologous transplant remains the preferred therapy for relapsed APL in CR2’, Bone Marrow Transplantation, vol. 51, no. 9, pp. 1180–1183.

Gilligan T, Coyle N, Frankel RM, Berry DL, Bohlke K, Epstein, RM, et al. 2017, ‘Patient–clinician communication: American Society of Clinical Oncology consensus guideline’, Journal of Clinical Oncology, vol. 35, no. 31, pp. 3618–3623.

Griggs J, Mangu P, Anderson H, Balaban E, Dignam J, Hryniuk W, et al. 2012, ‘Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline’, Journal of Clinical Oncology, vol. 30, no. 13, pp. 1553–1561.

Grimwade D, Ivey A, Juntly BJP 2016, ‘Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance’, Medical Journal of Australia, vol. 194, no. 3, pp. 107–108.

Gorin NC, Labopin M, Frassoni F, Milpied N, Attal M, Blaise D, et al. 2008, ‘Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8; 21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation’, Journal of Clinical Oncology, vol. 26, no. 19, pp. 3183–3188.

Hack TF, Reuther DJ, Weir LM, Grenier D, Degner LF 2012, ‘Promoting consultation recording practice in oncology: identification of critical implementation factors and determination of patient benefit’, Psycho-Oncology, vol. 22, pp. 1273–1282.

Haines IE 2011, ‘Managing patients with advanced cancer: the benefits of early referral for palliative care’, Medical Journal of Australia, vol. 194, no. 3, pp. 107–108.

Hayes SC, Newton RU, Spence RR, Galvao DA 2019, ‘The Exercise and Sports Science Australia position statement: exercise medicine in cancer management’, Journal of Science and Medicine in Sport, vol. 22, no. 11, pp. 1175–1199.

Hewitt M, Greenfield S, Stovall E 2006, From cancer patient to cancer survivor: lost in transition, National Academies Press, Washington.

Hilgendorf I, Greinix H, Halter JP, Lawitschka A, Bertz H, Wolff D 2015, ‘Long-term follow-up after allogeneic stem cell transplantation’, Deutsches Ärzteblatt International, vol. 112, pp. 51–58.

Holter Chakrabarty JL, Rubinger M, Le-Rademacher J, Wang HL, Grigg A, Selby GB, et al. 2014, ‘Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission’, Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, vol. 20, no. 7, pp. 1021–1025.

Jefford M, Ward AC, Lisy K, Lacey K, Emery JD, Glaser AW, et al. 2017, ‘Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study’, Support Care Cancer, no. 10, pp. 3171–3179.

Jones WC, Parry C, Devine S, Main DS, Sasaki SO, Tran ZV 2015, ‘Prevalence and predictors of distress in post-treatment adult leukemia and lymphoma survivors’, Journal of Psychosocial Oncology, vol. 33, no. 2, pp. 124–141.

Laidsaar-Powell R, Butow P, Boyle F, Juraskova 2018a, ‘Facilitating collaborative and effective family involvement in the cancer setting: guidelines for clinicians (TRIO guidelines-1)’, Patient Education and Counseling, vol. 101, no. 6, pp. 970–982.

Laidsaar-Powell R, Butow P, Boyle F, Juraskova 2018b, ‘Managing challenging interactions with family caregivers in the cancer setting: guidelines for clinicians (TRIO guidelines-2)’, Patient Education and Counselling, vol. 101, no. 6, pp. 983–994.

Lengfelder E, Lo-Coco F, Ades L, Montesinos P, Grimwade D, Kishore B, et al. 2015, ‘Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet’, Leukemia, vol. 29, no. 5, pp. 1084–1091.

Lisy K, Langdon L, Piper A, Jefford M 2019, ‘Identifying the most prevalent unmet needs of cancer survivors in Australia: a systematic review’, Asia-Pacific Journal of Clinical Oncology, vol. 15, no. 5, pp. e68–e78.

McMahon CM, Perl AE 2019, ‘Management of primary refractory acute myeloid leukemia in the era of targeted therapies’, Leukemia and Lymphoma, vol. 60, no. 3, pp. 583–597.

Monterosso L, Platt V, Bulsara M, Berg M 2019, ‘Systematic review and meta-analysis of patient reported outcomes for nurse-led models of survivorship care for adult cancer patients’, Cancer Treatment Reviews Journal, no. 73, pp. 62–72.

My Health Record 2019, ‘What is My Health Record?’ Australian Government, Sydney, viewed 17 December 2019, https://www.myhealthrecord.gov.au/for-you-your-family/what-is-my-health-record.

National Cancer Institute (NCI) 2020, Adult acute myeloid leukaemia treatment (PDQ) – health professional version, viewed 29 January 2020, https://www.cancer.gov/types/leukemia/hp/adult-aml-treatment-pdq#_AboutThis_1.

National Cancer Survivorship Initiative (NCSI) 2015, ‘Stratified pathways of care’, National Health Service, UK, viewed 2 March 2015.

National Comprehensive Cancer Network (NCCN) 2015, NCCN clinical practice guidelines in oncology – acute myeloid leukemia, NCCN 20th annual edition, version I, 2015, NCCN, Plymouth Meeting, PA.

National Comprehensive Cancer Network (NCCN) 2019, NCCN clinical practical guidelines in oncology: acute myeloid leukaemia, version 3.2020, NCCN, Plymouth Meeting, PA.

National Disability Insurance Agency 2018, ‘How the NDIS works’, NDIS, Canberra, viewed 3 June 2019, https://www.ndis.gov.au/understanding/how-ndis-works.

National Health and Medical Research Council (NHMRC) 2013, Personalised medicine and genetics, viewed 3 June 2019, https://www.nhmrc.gov.au/about-us/publications/personalised-medicine-and-genetics.

National Health and Medical Research Council (NHMRC) 2014, Talking with your patients about complementary medicine: a resource for clinicians, NHMRC, Canberra, viewed 18 February 2020, https://www.caresearch.com.au/caresearch/ClinicalPractice/PatientConsiderations/ComplementaryTherapies/tabid/1258/Default.aspx.

palliAGED 2018, ‘Needs Assessment’, Flinders University, Bedford Park, viewed 1 October 2019, https://www.palliaged.com.au/tabid/4879/Default.aspx.

Palliative Care Australia 2018, National Palliative Care Standards, 5th edn, Palliative Care Australia, Canberra, viewed 24 July 2019, http://palliativecare.org.au/wp-content/uploads/dlm_uploads/2018/11/PalliativeCare-National-Standards-2018_Nov-web.pdf.

Palliative Care Victoria 2019, ‘Spiritual care’, Palliative Care Victoria, Melbourne, viewed 22 July 2019, https://www.pallcarevic.asn.au/healthcare-professionals/about-palliative-care/care/spiritual-care/.

Perl A, Martinelli G, Cortes J, Neubauer A, Berman E, Paolini S, et al. 2019, ‘Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML’, New England Journal of Medicine, vol. 381. no. 18, pp. 1728–1740.

Peter MacCallum Cancer Centre 2019, Community support organisations’ cancer survivorship care consensus statement, viewed 10 February 2020, https://www.petermac.org/sites/default/files/media-uploads/NGO_ConsensusStatement.pdf.

Queensland Health 2015, Sad news sorry business: guidelines for caring for Aboriginal and Torres Strait Islander people through death and dying, State Government of Queensland, Brisbane, viewed 22 July 2019, https://www.health.qld.gov.au/__data/assets/pdf_file/0023/151736/sorry_business.pdf.

Schuurhuis GJ, Heuser M, Freeman S, Bene MC, Buccisano F, Cloos J, et al. 2018, ‘Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party’, Blood, vol. 131, no. 12, pp. 1275–1291.

Sharafeldin N, Bosworth A, Patel SK, Chen Y, Morse E, Mather M, et al. 2018, ‘Cognitive functioning after hematopoietic cell transplantation for hematologic malignancy: results from a prospective longitudinal study’, Journal of Clinical Oncology, vol. 36, no. 5, pp. 463–475.

Silver JK, Baima J 2013, ‘Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes’, American Journal of Physical Medicine & Rehabilitation, vol. 92, no. 8, pp. 715–727.

Silver JK 2015, ‘Cancer prehabilitation and its role in improving health outcomes and reducing health care costs’, Seminars in Oncology Nursing, vol. 31, no. 1, pp. 1–3.

Sjoquist K, Zalcberg J 2013, ‘Clinical trials – advancing cancer care’, Cancer Forum, vol. 37, no. 1, pp. 80–88.

Smith A, Bellizzi K, Keegan T, Zebrack B, Chen V, Neale A, et al. 2013, ‘Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience Study’, Journal of Clinical Oncology, vol. 31, no. 17, pp. 2136–2145.

Smith S, Case L, Waterhouse K, Pettitt N, Beddard L, Oldham J, et al. 2012, A blueprint of care for teenagers and young adults with cancer, Teenage Cancer Trust, Manchester, UK.

Sorror ML, Storer BE, Fathi AT, Gerds AT, Medeiros BC 2017, ‘Development and validation of a novel acute myeloid leukemia-composite model to estimate risks of mortality’, The Journal of the American Medical Association, vol. 3, no. 12, pp. 1675–1682.

Steer B, Marx G, Singhal N, McJannett M, Goldstein D, Prowse R 2009, ‘Cancer in older people: a tale of two disciplines’, Internal Medicine Journal, vol. 39, pp. 771–775.

Tan SY, Turner J, Kerin-Ayres K, Butler S, Deguchi C, Khatri S, et al. 2019, ‘Health concerns of cancer survivors after primary anti-cancer treatment’, Support Cancer Care, no. 10, pp. 3739–3747.

Temel J, Greer J, Muzikansky A, Gallagher E, Admane S, Jackson V 2010, ‘Early palliative care for patients with non-metastatic non-small cell lung cancer’, New England Journal of Medicine, vol. 363, no. 8, pp. 733–742.

Vardy JL, Raymond JC, Koczwara B, Lisy K, Cohn RJ, Joske D, et al. 2019, ‘Clinical Oncology Society of Australia position statement on cancer survivorship care’, Australian Journal of General Practice, vol. 48, no.12, pp. 833–836.

Venditti A, Piciocchi A, Candoni A, Melillo L, Calafiore V, Cairoli R, et al. 2019, ‘GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia’, Blood, vol. 134, no. 12, pp. 935–945.

Vijayvergia N, Denlinger CS 2015, ‘Lifestyle factors in cancer survivorship: where we are and where we are headed’, Journal of Personalized Medicine, vol. 5, no. 3, pp. 243–263.

Wildiers H, Heeren P, Puts M, Topinkova E, Maryska LG, Janssen-Heijnen MLG, et al. 2014, ‘International Society of Geriatric Oncology Consensus on geriatric assessment in older patients with cancer’, Journal of Clinical Oncology, vol. 32, no. 24, pp. 2595–2603.

Wingelhofer B, Somervaille TCP 2019, ‘Emerging epigenetic therapeutic targets in acute myeloid leukemia’, Frontiers in Oncology, vol. 9, pp. 850.

World Health Organization (WHO) 2018, ‘Malnutrition’, WHO, Geneva, viewed 18 July 2019, https://www.who.int/news-room/fact-sheets/detail/malnutrition.

Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, et al. 2014, ‘Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial’, Lancet, vol. 383, no. 9930, pp. 1721–1730.